The analysis of immunohistochemical staining showed that the infiltration of macrophage (MAC-III), T-cell (CD4+), MHC class-II, and Mast cells in AAA tissues was significantly increased with OVA-treatment (Fig. 2A-D). The gene discussed is CD4; the disease is triple-A syndrome.